Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?
Research and Practice in Thrombosis and Haemostasis, 2020 Background The benefit of vitamin K antagonists depends on the time within the therapeutic range (TTR). A patient’s previous TTR could be a factor in the decision to change the anticoagulation regimen.
Jasper H. A. vanMiert +2 more
doaj +1 more source
Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity [PDF]
Journal of Stroke, 2022 Background and purpose In acute stroke patients, plasma concentrations of direct oral anticoagulants (DOAC) at hospital admission only poorly mirror DOAC exposure or the coagulation status at the time of the event.
Timolaos Rizos +10 more
doaj +1 more source
Mechanical thrombextraction in patient with acute ischemic stroke on background of oral anticoagulant therapy [PDF]
Кардіохірургія та інтервенційна кардіологія, 2021 Thrombolytic therapy, which is a priority treatment strategy in patients with acute ischemic stroke in the first 3-4.5 hours after start of the disease, has significant limitations in case of background anticoagulant therapy. Mechanic thrombextraction is
V.О. Yarosh +5 more
doaj +1 more source
opensafely/anticoagulants-research
, 2021 Stata dataset, Python code and configuration files associated with a paper titled "Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies"
Walker, Alex +5 more
core +3 more sources
Oral anticoagulants: Optimizing venous thromboembolism management
Journal of Applied Hematology, 2019 A decade ago, oral anticoagulants were limited to Vitamin K antagonists, i.e., warfarin. Since 2010, the US Food and Drug Administration has approved several non-Vitamin K oral anticoagulants: dabigatran is a direct thrombin inhibitor, while apixaban ...
Fahad A S. Aleidan
doaj +1 more source
Use of anticoagulants in elderly patients: practical recommendations.
, 2009 International audienceElderly people represent a patient population at high thromboembolic risk, but also at high hemorrhagic risk. There is a general tendency among physicians to underuse anticoagulants in the elderly, probably both because of ...
Grégoire Le Gal +9 more
core +1 more source
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management
Brain Sciences, 2020 Background: Atrial fibrillation (AF) is a risk factor for cerebrovascular diseases and vascular dementia (VAD). The aim of this study was to evaluate the effect of the adherence to anticoagulant therapy guidelines in patients with dementia and AF on the ...
Giovanna Viticchi +7 more
doaj +1 more source
Anticoagulation in cirrhosis [PDF]
Liver International, 2012 The Authors review and comment a recent publication by Senzolo et al.
VILLA, Erica, N. De Maria
openaire +3 more sources
BMC Gastroenterology, 2019 Background Heparin bridging therapy (HBT) is indeed related to a high frequency of bleeding after endoscopic mucosal resection (EMR). In this study, our aim was to investigate clinical impact of management of oral anticoagulants without HBT in bleeding ...
Shoko Ono +6 more
doaj +1 more source
A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) [PDF]
The Korean Journal of Internal Medicine, 2020 Background/Aims Efforts to reduce stroke in patients with atrial fibrillation (AF) have focused on increasing physician adherence to oral anticoagulant (OAC) guidelines; however, the high early discontinuation rate of vitamin K antagonists (VKAs) is a ...
Hyeongsoo Kim +15 more
doaj +1 more source